29th week of 2010 patent applcation highlights part 37 |
Patent application number | Title | Published |
20100183963 | METHOD FOR DESIGN AND MANUFACTURE OF A RETICLE USING A TWO-DIMENSIONAL DOSAGE MAP AND CHARGED PARTICLE BEAM LITHOGRAPHY - In the field of semiconductor device production, a method for manufacturing a surface using two-dimensional dosage maps is disclosed. A set of charged particle beam shots for creating an image on the surface is determined by combining dosage information such as dosage maps for a plurality of shots into the dosage map for the surface. A similar method is disclosed for fracturing or mask data preparation of a reticle image. | 2010-07-22 |
20100183964 | ELECTROSTATIC IMAGE DEVELOPING GREEN TONER, ELECTROSTATIC IMAGE DEVELOPER, ELECTROSTATIC IMAGE DEVELOPING TONER SET, ELECTROSTATIC IMAGE DEVELOPER SET AND IMAGE FORMING APPARATUS - An electrostatic image developing green toner includes: a binder resin; a coloring agent; and a release agent, and the electrostatic image developing green toner satisfying the following equations: | 2010-07-22 |
20100183965 | RED TONER FOR ELECTROSTATIC IMAGE DEVELOPMENT, DEVELOPER FOR ELECTROSTATIC IMAGE DEVELOPMENT, TONER SET FOR ELECTROSTATIC IMAGE DEVELOPMENT, DEVELOPER SET FOR ELECTROSTATIC IMAGE DEVELOPMENT AND IMAGE FORMING APPARATUS - A red toner for electrostatic image development, includes: a binder resin; a coloring agent; and a release agent, wherein the red toner for electrostatic image development satisfies the following formulae: | 2010-07-22 |
20100183966 | TONER SET FOR ELECTROSTATIC IMAGE DEVELOPMENT, IMAGE FORMING METHOD AND IMAGE FORMING APPARATUS - A toner set for electrostatic image development, includes: at least one kind of a colored toner that contains a coloring agent; and a transparent toner that does not substantially contain a coloring agent, wherein a proportion of particles having a shape factor of 0.94 or less in mother particles of the transparent toner is about 5% by number or less based on particles having a particle diameter of 7.5 to 15 μm, and a reflectance of the mother particles of the transparent toner is about 90% or more for light at a wavelength of 700 nm. | 2010-07-22 |
20100183967 | TONER, COLOR TONER SET, DEVELOPER, PROCESS CARTRIDGE, AND IMAGE FORMING METHOD - A toner including a binder resin comprising a resin (a) comprising a polyhydroxycarboxylic acid skeleton formed from an optically-active monomer. The polyhydroxycarboxylic acid skeleton has a weight average molecular weight of from 7,000 to 60,000. The binder resin comprises the polyhydroxycarboxylic acid skeleton in an amount of from 10 to 90% by weight. The optical purity X (%) of the polyhydroxycarboxylic acid skeleton represented by the following formula is 80% or less: | 2010-07-22 |
20100183968 | TRANSPARENT TONER FOR DEVELOPING ELECTROSTATIC LATENT IMAGE, ELECTROSTATIC LATENT IMAGE DEVELOPER, TONER CARTRIDGE, PROCESS CARTRIDGE, IMAGE FORMING APPARATUS AND IMAGE FORMING METHOD - The invention provides a transparent toner for developing an electrostatic latent image, including a binder resin and a release agent, the difference between the endothermic peak Tm of the release agent in a temperature increasing process and the exothermic peak Tc of the release agent in a temperature decreasing process being from about 10° C. to about 50° C., where Tm and Tc are measured with a differential scanning calorimeter (DSC) according to the ASTM method. | 2010-07-22 |
20100183969 | CROSSLINKED RESIN PARTICLE DISPERSION LIQUID - The present invention relates to a toner for electrophotography which has a small particle size and is excellent in all of low-temperature fusing ability, anti-hot offset property and image characteristics and a process for producing the toner, as well as to a dispersion of crosslinked resin particles which is used for production of the toner for electrophotography and a process for producing the dispersion of crosslinked resin particles. The dispersion of crosslinked resin particles having a volume median particle size (D | 2010-07-22 |
20100183970 | ELECTROSTATIC IMAGE DEVELOPING CARRIER, ELECTROSTATIC IMAGE DEVELOPER, PROCESS CARTRIDGE, IMAGE FORMING METHOD, AND IMAGE FORMING APPARATUS - An electrostatic image developing carrier includes a ferrite particle that contains magnesium element in an amount of about 3.0 wt % or more and about 10.0 wt % or less and manganese element in an amount of about 0.2 wt % or more and less than about 1.0 wt %; and a resin layer that covers the ferrite particle. | 2010-07-22 |
20100183971 | MAGNETIC CARRIER, TWO-COMPONENT DEVELOPER AND IMAGE FORMING METHOD - A magnetic carrier having magnetic carrier particles each containing at least a magnetic core particle and a resin; the magnetic carrier having a resistivity of from 1.0×10 | 2010-07-22 |
20100183972 | Image-bearing member protecting agent, protective layer forming device, image forming method, image forming apparatus, and process cartridge - An image-bearing member protecting agent including: a hydrophobic organic compound (A); an inorganic lubricant (B); and inorganic fine particles (C), wherein each of the inorganic fine particles (C) has a specific surface area of 2.0 m | 2010-07-22 |
20100183973 | PHOTOCONDUCTIVE LAYER MANUFACTURING METHOD - A method for manufacturing a photoconductive layer formed of Bi | 2010-07-22 |
20100183974 | COMPOUND, METHOD FOR PRODUCING SAME, POSITIVE RESIST COMPOSITION AND METHOD FOR FORMING RESIST PATTERN - A compound of the present invention is a compound represented by a general formula (A-1) [wherein, R′ represents a hydrogen atom or an acid-dissociable, dissolution-inhibiting group, provided that at least one R′ group is an acid-dissociable, dissolution-inhibiting group, R | 2010-07-22 |
20100183975 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMING METHOD USING THE SAME, AND RESIN - Provided is a actinic ray-sensitive or radiation-sensitive resin composition including (P) a resin containing (A) a repeating unit having an ionic structure moiety that contains a cation represented by formula (Ia) and is capable of producing an acid anion on the side chain upon irradiation with an actinic ray or radiation: | 2010-07-22 |
20100183976 | Compositions and processes for photolithography - Topcoat layer compositions are provided that are applied above a photoresist composition. The compositions find particular applicability to immersion lithography processing. | 2010-07-22 |
20100183977 | Compositions and processes for photolithography - Topcoat layer compositions are provided that are applied above a photoresist composition. The compositions find particular applicability to immersion lithography processing. | 2010-07-22 |
20100183978 | SURFACE-TREATING AGENT FOR PATTERN FORMATION AND PATTERN FORMING METHOD USING THE TREATING AGENT - There are provided a surface-treating agent containing a specific compound having an amino group and an aromatic ring as a surface-treating agent for a freezing process for chemically treating a first resist pattern used in a freezing process of chemically treating and thereby qualitatively changing the first resist pattern so as not to dissolve in a second resist solution in order to form a second resist film on the first resist pattern and form a second resist pattern after the first resist pattern is formed on a first resist film, wherein the surface-treating agent performs a chemical treatment on the first resist pattern to satisfy the requirements that the first resist pattern does not dissolve in the second resist solution, the dimension of the first resist pattern is not changed, and the first resist pattern and the second resist pattern have the same dry etching resistance; and a pattern forming method using the surface-treating agent. | 2010-07-22 |
20100183979 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION AND PATTERN FORMING METHOD USING THE SAME - An actinic ray-sensitive or radiation-sensitive resin composition includes (A) a compound capable of generating a specific acid having a norbornyl structure upon irradiation with an actinic ray or radiation, and (B) a resin capable of increasing the dissolution rate of the resin (B) in an alkali developer by an action of an acid, the resin (B) containing a specific repeating unit having a lactone structure on the resin side chain through a linking group, and a pattern forming method uses the composition. | 2010-07-22 |
20100183980 | ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION AND PATTERN FORMING METHOD USING THE SAME - An actinic ray-sensitive or radiation-sensitive resin composition includes: (A) a compound capable of generating an acid upon irradiation with an actinic ray or radiation; (B) a resin capable of increasing a dissolution rate of the resin (B) in an alkali developer by an action of an acid, the resin (B) containing a specific repeating unit having a lactone structure; and (D) a low molecular compound having a group capable of leaving by an action of an acid, and a pattern forming method uses the composition. | 2010-07-22 |
20100183981 | Positive resist composition and method of forming resist pattern - A positive resist composition including a base component (A) which exhibits increased solubility in an alkali developing solution under action of acid and an acid-generator component (B) which generates acid upon exposure, the base component (A) including a polymeric compound (A1) containing a structural unit (a0) represented by general formula (a0-1), a structural unit (a1) derived from an acrylate ester containing an acid dissociable, dissolution inhibiting group, and a structural unit (a3) derived from an acrylate ester containing a hydroxy group-containing aliphatic hydrocarbon group represented by general formula (a3-1), and the amount of the structural unit (a3) based on the combined total of all structural units constituting the polymeric compound (A1) being in the range of 1 to 30 mol %. | 2010-07-22 |
20100183982 | METHOD OF MANUFACTURING A SEMICONDUCTOR DEVICE - A method of fabricating a semiconductor device according to an embodiment includes: forming a first resist pattern made of a first resist material on a workpiece material; irradiating an energy beam onto the first resist pattern, the energy beam exposing the first resist material to light; performing a treatment for improving resistance the first resist pattern after irradiation of the energy beam; forming a coating film on the workpiece material so as to cover the first resist pattern; and forming a second resist pattern made of a second resist material on the coating film after the treatment. | 2010-07-22 |
20100183983 | PROCESS FOR MANUFACTURING ELECTRONIC DEVICE - A process of this invention contains forming a resin composition containing a filler and a photocurable resin over a substrate (a transparent substrate | 2010-07-22 |
20100183984 | MULTIPLEXING OF PULSED SOURCES - A process and related apparatus for generating an output radiation through an output aperture, including generating pulsed radiations by a plurality of radiation sources, each source being arranged for respectively (i) generating within a respective plasma a respective pulsed elementary radiation whose wavelengths include a respective desired range, and (ii) directing rays of its respective elementary radiation on the output aperture. For each source, refractive indices of rays are distributed in a respective control region through which its respective elementary radiation passes and located in its respective plasma, to selectively deviate rays of its respective elementary radiation as a function of their wavelength, and temporally multiplexing the radiation sources to obtain at the output aperture the output radiation. | 2010-07-22 |
20100183985 | PROCESS FOR PRODUCING SEMICONDUCTOR DEVICE - A process for producing a semiconductor device includes a circuit formation step of forming circuit wiring on a semiconductor wafer using a chemically-amplified resist, and a cured film formation step of forming a cured film that protects the circuit wiring after forming the circuit wiring, the cured film being formed of a cured material of a photosensitive resin composition that comprises an alkali-soluble resin having a polybenzoxazole structure or a polybenzoxazole precursor structure, a compound that generates an acid upon exposure to light, and a solvent. The photosensitive resin composition substantially does not contain N-methyl-2-pyrrolidone. The process can suppress a T-top phenomenon or the like that may occur when forming a circuit on a semiconductor wafer using a chemically-amplified resist in the production of semiconductor devices. | 2010-07-22 |
20100183986 | STAMPER PRODUCTION METHOD AND READ-ONLY OPTICAL DISC PRODUCTION METHOD - A stamper production method includes: a stamper forming step of producing, by electroplating processing using a matrix in which a pit string constituted of a concave pit is formed on an inorganic resist layer based on recording information, a stamper on which a convex pit corresponding to the concave pit is formed; and an etching step of carrying out etching processing on the stamper so that a reduction ratio of a pit height of a short pit becomes larger than that of a long pit regarding the convex pit of the stamper. | 2010-07-22 |
20100183987 | EXPOSURE APPARATUS - An exposure apparatus for exposing a substrate to radiant energy in a vacuum is disclosed. The apparatus comprises a chamber in which the vacuum is generated, a blowing device including a supply nozzle ( | 2010-07-22 |
20100183988 | EXPOSURE SYSTEM AND PATTERN FORMATION METHOD - An exposure system includes a cleaning unit for cleaning a surface of a resist film formed on a wafer with a cleaning fluid and an exposure unit for performing pattern exposure with an immersion liquid provided between the resist film and a projection lens. | 2010-07-22 |
20100183989 | Air-Gas Pilot Burner that can Operate with Oxygen - A system includes at least one pilot burner and one more powerful main burner. The pilot burner includes at least a first tube open at an end and including at least a first feedline capable of injecting a combustible gas into the first tube. The pilot burner further includes at least a second tube open at an end and including at least a third feedline capable of injecting an oxygen-rich gas into the second tube. The pilot burner further includes at least a second feedline capable of feeding the first tube with air. | 2010-07-22 |
20100183990 | Multi-Mode Combustion Device and Method for Using the Device - An apparatus for continuation of combustion with a combustion apparatus when the supply of the normal operating oxidant or normal operating fuel is disrupted, or temporally reduced. Air or oxygen enriched air or oxygen and a gaseous fuel or a liquid fuel or both a gaseous and liquid fuel are introduced into the combustion apparatus in place of the normal oxidant-fuel mixture to effect combustion and maintain the heating level in the furnace. | 2010-07-22 |
20100183991 | Premixing burner and method for operating a premixing burner - A method for operating a premixing burner is provided. The premixing burner includes a premixing zone. An air mass flow and fuel may be injected into the premixing zone, and a potential hot gas backflow area may form. A fluid containing no fuel is injected downstream from the fuel injection into the premixing zone in order that a hot gas backflow area does not form. A premixing burner including a premixing zone is also provided. | 2010-07-22 |
20100183992 | DEVICE FOR LIMITING THE EXHAUSTING OF COMBUSTION FLUE GASES AT THE INLET OF A FURNACE FOR REHEATING STEEL PRODUCTS - The invention relates to a device for limiting the combustion fume exhaust towards the outside of a continuous furnace, especially a tunnel furnace, for reheating iron and steel products, especially slabs, at the opening located at the entrance of the furnace. The first row of burners consists of at least two burners ( | 2010-07-22 |
20100183993 | Integrated fuel injectors and igniters and associated methods of use and manufacture - The present disclosure is directed to injectors with integrated igniters providing efficient injection, ignition, and complete combustion of various types of fuels. These integrated injectors/igniters can include, for example, insulators with adequate mechanical and dielectric strength to enable high-energy plasma generation by components that have very small dimensions, multifunction valving that is moved to injector multiple bursts of fuel and to induce plasma projection, a fuel control valve at the interface to the combustion chamber for the purpose of eliminating fuel drip at undesired times, and one or more components at the interface of the combustion chamber for the purpose of blocking transmission of combustion sourced pressure. | 2010-07-22 |
20100183994 | Method of Monitoring an Exhaust Fumes Main Linking a Carbon Block Baking Furnace to a Fume Treatment - The method of the invention is used for monitoring the state of a smoke duct connecting each suction rail of a baking furnace (FAC) for carbonated blocks, of the rotating fire type and preferably with open chambers or covered chambers, to a smoke processing centre (CTF) for purifying the baking smoke from the FAC, wherein said smoke is drawn through at least one suction rail of the FAC and collected in the smoke duct feeding said smoke to the CTF, the method including at least the step of detecting a leak in the smoke duct consisting of parasitic inlets of ambient air into said duct and/or at least the step of detecting a fire in said duct. | 2010-07-22 |
20100183995 | Adhesive label manufacturing device and adhesive label manufacturing method - A heat-sensitive adhesive label manufacturing device includes: a thermal head ( | 2010-07-22 |
20100183996 | CONTAINERS FOR PHOTOCURABLE MATERIALS - Containers for photocurable materials are made of a polymer and metallic particles. The containers are particularly useful for storing materials having dyes that are highly sensitive to light. The containers are especially useful for storing dental materials such as orthodontic adhesives, including adhesives in syringes and cartridges as well as adhesives that are precoated onto the base of an orthodontic appliance. | 2010-07-22 |
20100183997 | APPARATUS AND METHODS FOR CORRECTION OF ORTHODONTIC MALOCCLUSIONS - A sequential orthodontic appliance comprising a body ( | 2010-07-22 |
20100183998 | DENTAL PROSTHESIS SYSTEM - The present disclosure relates to a dental prosthesis system and a method of using same comprising a prosthesis, a primary bar, and a base-plate. The primary bar is adapted to be received on the implants and to be used as a superstructure for supporting the prosthesis, a verification jig and/or an impression matrix. The base-plate has a shape adapted to be received on the patient's gum surface, comprising at least one hole each in alignment with a corresponding one of the aperture of the primary bar when the primary bar is seated on the base-plate, each hole of the base-plate correspond to the position of each implant hole, the base-plate supporting the primary bar to form a drilling guide for guiding the drilling of implants holes in the patient's gum surface. | 2010-07-22 |
20100183999 | CURABLE DENTAL RETRACTION COMPOSITION, METHOD OF PRODUCTION AND USE THEREOF - The invention relates to a curable dental retraction composition for reacting gingiva from a prepared tooth structure. The composition comprises an alginate, a di- and/or trivalent ion source, water, a retarder and a filler. | 2010-07-22 |
20100184000 | PERIODONTAL SCALER - A periodontal scaler is provided, comprising an arcuate shank and an arcuate blade. The arcuate blade being designed to conform to the roughly cylindrical surfaces found on the roots of teeth. This conforming feature of the instrument's blade increases its cleaning efficiency by maximizing contact between the blades surface and the root, and guiding the instrument along the root by holding its convex edges within the concave shape of the blade. | 2010-07-22 |
20100184001 | AREA-SPECIFIC DENTAL INSTRUMENT - An area-specific dental instrument is provided, which comprises an arcuate S-shaped shank and an arcuate blade further comprising a sharpened convex surface. This instrument can be capable of cleaning plaque and calculus from the lingual surfaces of anterior teeth and concave surfaces between teeth at the cemento-enamel junction. | 2010-07-22 |
20100184002 | TRANSFER COPINGS AND RELATED METHODS FOR TAKING IMPLANT IMPRESSIONS - A transfer coping configured to take an impression of an implant is disclosed. The transfer coping has an impression material contact portion and an implant mating portion. The implant mating portion has at least one support portion and at least one deflection portion configured to be received within an opening on a coronal portion of an implant. The at least one protrusion is disposed on the at least one deflection portion and is configured to engage in a snap-fit manner with a coordinating feature of an implant. A method for identifying the position of an implant in a patient is also disclosed. | 2010-07-22 |
20100184003 | DENTAL TRANSFER FOR FIXING THE POSITION OF ENDOSSEOUS IMPLANTS IN DENTAL ARCHES - Dental transfer ( | 2010-07-22 |
20100184004 | ANGULATED ATTACHMENT DEVICE FOR DENTAL PROSTHESES - The present invention relates an angulated ball attachment device which is deployed such that the ball component is off-set from the central axis of the implant. The ball component and the abutment base element form a single rigid unit that is stable even in case the attachment screw of the device becomes loosened. | 2010-07-22 |
20100184005 | METHOD FOR PROVIDING AN OPERATOR OF A VEHICLE WITH OPERATING INFORMATION - A method for providing an operator of a vehicle with operating information includes providing at least one predetermined demonstration of the operating information, deciding if one of the at least one predetermined demonstration is desired to be presented to the operator and, if desired, automatically presenting the demonstration to the operator in an operator compartment of the vehicle when the operator is in an operational position. | 2010-07-22 |
20100184006 | Aromatic Test Kit - The invention generally relates to familiarization and training in practice and art of olfactory recognition of wine properties. The invention relates to a kit which is a package containing samples of aromatic solutions and corresponding information cards. In one embodiment, the invention relates to the use of certain chemical compounds within a kit for teaching odor recognition relevant to wine evaluation. | 2010-07-22 |
20100184007 | EDUCATIONAL GAME APPARATUS - Disclosed is an educational game apparatus for playing a game by a plurality of players. The educational game apparatus comprises a playing rack member, a pair of dice, and a winner indication member. The playing rack member comprises a pair of lateral members, and a plurality of transverse members coupled to configure a turn record section, a score record section, and a number section. The turn record section records turns played by a player during the game, and records a lucky number selected by the player. The score record section records scores accumulated by the player during the game. The number section includes a plurality of blocks each with a set of numbers inscribed thereon. The pair of dice is tossed to turn a block from the plurality of blocks to score points. Further, the player with highest points secures the winner indication member on the playing rack member. | 2010-07-22 |
20100184008 | 3D EFFECT TOPOGRAPHICAL MAPS AND METHOD OF MAKING SAID MAPS - A weatherproof topographical map having a 3D image effect printed on a weatherproof flexible fabric allowing the production of a map which is easy to use and store without the tendency to lose detail along fold lines. And a method of making a weatherproof topographical map having a 3D image effect particularly suitable for use by outdoor users having weatherproof/waterproof features as well as 3D rendering of elevations and easy to find and read information. | 2010-07-22 |
20100184009 | TEACHING AND ASSESSMENT METHODS AND SYSTEMS - The invention relates to methods and systems for teaching and assessing a set of targets to a student, particularly in the field of literacy. One application of the invention is in teaching sound-symbol relationships. The invention using a rapid learning system, whereby each target is associated with a completion score and a student score. A student is prompted to identify a particular target (from a number of options). When the student correctly identifies a target, the student score is incremented until it reaches a completion score. The student score is decremented for incorrect responses. A support mechanism (e.g. a mnemonic) may be provided to the student—as a student shows increased proficiency, the level of support is reduced. This may be done by “morphing” the mnemonic into a standard representation of the target. Associated methods and systems are also disclosed. | 2010-07-22 |
20100184010 | Boxing punching combination training/workout system - My boxing punching combination system is the idea of identifying specific numbers to represent specific punches and having them placed at the proper location for those punches. By placing these numbers appropriately on any given apparatus, any user can easily execute boxing punching combinations regardless of the user's level of experience in boxing. | 2010-07-22 |
20100184011 | MACHINE, SYSTEM AND METHOD FOR USER-GUIDED TEACHING OF DEICTIC REFERENCES AND REFERENT OBJECTS OF DEICTIC REFERENCES TO A CONVERSATIONAL COMMAND AND CONTROL SYSTEM - A machine, system and method for user-guided teaching of deictic references and referent objects of deictic references to a conversational system. The machine includes a system bus for communicating data and control signals received from the conversational system to the computer system, a data and control bus for connecting devices and sensors in the machine, a bridge module for connecting the data and control bus to the system bus, respective machine subsystems coupled to the data and control bus, the respective machine subsystems having a respective user interface for receiving a deictic reference from a user, a memory coupled to the system bus for storing deictic references and objects of the deictic references learned by the conversational system and a central processing unit coupled to the system bus for executing the deictic references with respect to the objects of the deictic references learned. | 2010-07-22 |
20100184012 | METHODS AND DEVICES FOR IMAGING AND MANIPULATING BIOLOGICAL SAMPLES - Methods of imaging biological samples are provided. Aspects of embodiments of the methods include freezing, thawing and imaging a biological sample, one or more times, in a manner sufficient to image the biological sample while maintaining the viability and/or structural integrity of the sample. Also provided are devices and systems for use in practicing the methods. | 2010-07-22 |
20100184013 | DETECTION OF OLIGOSACCHARIDES - Provided herein are processes for detecting oligosaccharides in a biological sample. In specific instances, the biological sample is provided from an individual suffering from a disorder associated with abnormal glycosaminoglycan accumulation. | 2010-07-22 |
20100184014 | Non-M, non-O HIV-1 strains, fragments and uses - Retroviral strains of the non-M, non-O HIV-1 group, in particular a strain designated YBF30, its fragments and also its uses as a diagnostic reagent and as an immunogenic agent. | 2010-07-22 |
20100184015 | METHOD FOR DETECTION OF XMRV - The present invention relates to the identification of Xenotropic murine leukemia virus (XMRV) nucleic acid by polymerase chain reaction (PCR) analysis (e.g., real time PCR (RT/PCR); nested RT/PCR using Tth DNA polymerase and Hot start polymerase) and the uses thereof. In particular, the invention provides methods for the detection, and in particular early detection, of XMRV in RNA isolated from samples (e.g., urine samples; expressed prostate secretion (EPS)) of prostate cancer patients and normal individuals. | 2010-07-22 |
20100184016 | METHODS AND COMPOSITIONS IN THE TREATMENT OF PORCINE CIRCOVIRAL INFECTION - The invention relates generally to the field of virology. More particularly, the present invention relates to methods of diagnosing, prognosis, treatment and prevention of porcine circoviral infection in mammals, in particular of porcine circovirus type 2 (PCV2). | 2010-07-22 |
20100184017 | DIFFERENTIAL AMPLIFICATION OF MUTANT NUCLEIC ACIDS BY PCR IN A MIXTURE OF NUCLEIC ACIDS - A method for enriching a mutant nucleic acid in a mixture of nucleic acids, wherein the method comprises: (a) providing a nucleic acid mixture comprising a parental nucleic acid and a mutant nucleic acid of the parental nucleic acid; and (b) amplifying the nucleic acids in the nucleic acid mixture by polymerase chain reaction (PCR); wherein the mutant nucleic acid is a G→A mutant of the parental nucleic acid, which pairs with a fully complementary nucleic acid sequence to form an AT-rich nucleic acid variant of the parental nucleic acid; and wherein the AT-rich nucleic acid variant is denatured and selectively amplified by carrying out PCR using a denaturation temperature 1-3° C. lower than the lowest denaturation temperature (T | 2010-07-22 |
20100184018 | Detection of Herpes Simplex Virus - The invention provides methods to detect herpes simplex virus (HSV) in biological samples and further to distinguish between HSV-1 and HSV-2. Primers and probes for the differential detection of HSV-1 and HSV-2 are provided by the invention. Articles of manufacture containing such primers and probes for detecting HSV are further provided by the invention. | 2010-07-22 |
20100184019 | Novel Human Virus Causing Severe Acute Respiratory Syndrome (SARS) and Uses Thereof - The present invention relates to an isolated novel virus causing Severe Acute Respiratory Syndrome (SARS) in humans (“hSARS virus”). The hSARS virus is identified to be morphologically and phylogenetically similar to known member of Coronaviridae. The present invention provides the complete genomic sequence of the hSARS virus. Furthermore, the invention provides the nucleic acids and peptides encoded by and/or derived from the hSARS virus and their use in diagnostic methods and therapeutic methods, including vaccines. In addition, the invention provides chimeric or recombinant viruses encoded by said nucleotide sequences and antibodies immunospecific to the polypeptides encoded by the nucleotide sequences. | 2010-07-22 |
20100184020 | Chip-Based Sequencing Nucleic Acids - A system for fast DNA sequencing by amplification of genetic material within microreactors, denaturing, demulsifying, and then sequencing the material, while retaining it in a PCR/sequencing zone by a magnetic field. One embodiment includes sequencing nucleic acids on a microchip that includes a microchannel flow channel in the microchip. The nucleic acids are isolated and hybridized to magnetic nanoparticles or to magnetic polystyrene-coated beads. Microreactor droplets are formed in the microchannel flow channel. The microreactor droplets containing the nucleic acids and the magnetic nanoparticles are retained in a magnetic trap in the microchannel flow channel and sequenced. | 2010-07-22 |
20100184021 | NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND METHODS OF USE THEREOF FOR DIAGNOSIS - The present invention relates to diagnostic markers comprising novel splice variants of known proteins and polynucleotides encoding same, useful in the qualitative and/or quantitative detection of various diseases and/or pathological conditions in a subject, and to the use of known proteins and polynucleotides encoding same for diagnosis. Particularly, the invention relates to the diagnosis of a disease in a sample of body fluid or secretion obtained from the subject, and to the diagnosis of cancer. | 2010-07-22 |
20100184022 | Hybridization Probe Assay and Array - A probe suitable for coupling with a particulate support such as a microbead, the probe comprising:
| 2010-07-22 |
20100184023 | Prostate Specific Gene, PCGEM1, and Methods of Using PCGEM1 to Detect, Treat, and Prevent Prostate Cancer - A nucleic acid sequence that exhibits prostate-specific expression and over-expression in tumor cells is disclosed. The sequence and fragments thereof are useful for detecting, diagnosing, preventing, and treating prostate cancer and other prostate related diseases. The sequence is also useful for measuring hormone responsiveness of prostate cancer cells. | 2010-07-22 |
20100184024 | Method of Characterizing Nucleic Acids in a Mixed Sample - A method is provided for characterizing a mixed sample having at least two particles with nucleic acids from different individuals, where each particle has nucleic acid from one or more individuals, in particular for the quantitative determination of the absolute and/or relative copy number of a predetermined sequence of an individual, of which nucleic acid is present in the mixed sample, having the steps:
| 2010-07-22 |
20100184025 | METHOD FOR SCREENING FOR A TOBIANO COAT COLOR GENOTYPE - A method for screening for a Tobiano genotype includes obtaining a nucleic acid from an equine animal, and analyzing the nucleic acid for the presence of an inversion in a chromosome ECA3q which is indicative of the genotype for Tobiano. The method includes detecting at least one of a telomeric breakpoint of an inverted ECA3q chromosome and/or a centromeric breakpoint of an inverted ECA3q chromosome. In one embodiment, the nucleic acid may be analyzed by the steps of hybridizing the group of probes or primers having the sequences set forth herein in SEQ ID NO:8, SEQ ID NO: 9, and SEQ ID NO: 10, or sequences complementary thereto, and preparing an amplification product. A 209 bp nucleic acid amplification product (SEQ ID NO:11) indicates the presence of the inversion. | 2010-07-22 |
20100184026 | Companion Diagnostic Assays For Endothelin Receptor Antagonists - Methods for identifying cancer patients eligible to receive endothelin receptor antagonist therapy and for monitoring patient response to endothelin receptor antagonist therapy comprise assessment of the expression levels of at least one of PAI-1, uPA, TGFbeta2, IL-6, IL-8 and OPG in a patient tissue sample. The methods of the invention allow more effective identification of patients to receive endothelin receptor antagonist therapy and of determination of patient response to the therapy. | 2010-07-22 |
20100184027 | METHODS AND NUCLEIC ACIDS FOR ANALYSES OF CELLULAR PROLIFERATIVE DISORDERS - The invention provides methods, nucleic acids and kits for detecting, or for detecting and distinguishing between or among proliferative disorders. The invention discloses genomic sequences the methylation patterns of which have utility for the improved detection of and differentiation between said class of disorders, thereby enabling the improved diagnosis and treatment of patients. | 2010-07-22 |
20100184028 | METHOD AND SYSTEM FOR REAL TIME QUANTIFICATION AND MONITORING OF NUCLEIC ACID AMPLIFICATION USING ELECTROCONDUCTIVE OR ELECTROCHEMICALLY ACTIVE LABELS - A method and device for real time electrochemically or electrically monitoring and detecting nucleic acid amplification products, i.e. after each polymerase chain reaction cycle, utilizes electrochemically active or electrically conductive reporter materials. An electric voltage is applied and electric signals are measured during a PCR amplification process to the electrodes that is suitable for quantifying the amplified products of a sample's nucleic acid(s) produced. This technique is suitable for point-of-use applications, e.g. detecting bioanalytes in remote locations. | 2010-07-22 |
20100184029 | METHODS AND COMPOSITIONS FOR IDENTIFYING BIOMARKERS USEFUL IN CHARACTERIZING BIOLOGICAL STATES - The present invention relates to methods, compositions, and kits for identifying biomarkers useful in characterizing biological states. In particular, the invention relates to methods and compositions for molecular characterization of biological states by gene expression profiling. The invention also relates to assessing effects of DNA polymorphisms on regulation of transcription. The biomarkers and polymorphisms identified find use in diagnostic and treatment approaches, e.g., some embodiments of the invention provide methods and kits for detecting bronchogenic carcinoma and risks thereof. | 2010-07-22 |
20100184030 | METHOD, COMPOSITIONS AND KITS FOR INCREASING EFFICIENCY OR SPECIFICITY OF HYBRIDIZATION BETWEEN PNA PROBES IMMOBILIZED ON SUPPORT AND TARGET NUCLEIC ACIDS - Disclosed are a process for increasing efficiency or specificity of hybridization between peptide nucleic acid (PNA) probes immobilized on a support and target nucleic acids, which comprises the step of fragment the target nucleic acids to reduce the size of the target nucleic acids, or selectively degrading the target nucleic acids which mismatch with the PNA probes, in the hybridization reaction between the PNA probes supported on a support and the target nucleic acids; and a composition and a kit therefor. | 2010-07-22 |
20100184031 | NOVEL ADIPOCYTOKINE VISFATIN/PBEF1 IS AN APOPTOSIS ASSOCIATED FACTOR INDUCED IN MONOCYTES DURING IN VIVO HIV-1 INFECTION - The present invention relates to the use of monocyte markers for diagnostic, prognostic or theranostic applications during diseases and syndromes caused by HIV infection. More specifically, it relates to a method comprising isolation of monocytes and determining gene expression, preferably PBEF1 gene expression. The method is useful to determine the evolution of the disease or can be used to evaluate the efficacy of a treatment. | 2010-07-22 |
20100184032 | Stem-Progenitor Cell Specific Micro-Ribonucleic Acids and Uses Thereof - Provided herein are methods and compositions for modulating the differentiation of incompletely differentiated cells, such as stem-progenitor cells, e.g., hematopoietic stem-progenitor cells. A method may comprise contacting a cell with an agononist or an antagonist of a miRNA comprising a nucleotide sequence from SEQ ID NO: 1-34. | 2010-07-22 |
20100184033 | METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY - Aspects of the present invention relate to methods to differentiate pluripotent primordial stem cells, such as human embryonic stem (“hES”) cells, human embryonic germ (“hEG”) cells, human embryo-derived (“hED”) cells and human embryonal carcinoma (“hEC”) cells, to obtain subpopulations of cells from heterogeneous mixtures of cells, wherein the subpopulation of cells possess reduced differentiation potential compared to the original pluripotent stem cells and where the subpopulation is capable of being propagated 20 or more population doublings. This invention also provides novel compositions of such subpopulations of cells and methods to propagate and differentiate said cells. | 2010-07-22 |
20100184034 | Gene Expression Profiling for Identification, Monitoring and Treatment of Lung Cancer - A method is provided in various embodiments for determining a profile data set for a subject with lung cancer or conditions related to lung cancer based on a sample from the subject, wherein the sample provides a source of RNAs. The method includes using amplification for measuring the amount of RNA corresponding to at least 1 constituent from Tables 1-5. The profile data set comprises the measure of each constituent, and amplification is performed under measurement conditions that arc substantially repeatable. | 2010-07-22 |
20100184035 | METHODS FOR RAPID FORENSIC DNA ANALYSIS - The present invention provides methods and primer pairs for rapid, high-resolution forensic analysis of DNA and STR-typing by using amplification and mass spectrometry, determining the molecular masses and calculating base compositions of amplification products and comparing the molecular masses with the molecular masses of theoretical amplicons indexed in a database. | 2010-07-22 |
20100184036 | METHODS FOR DETECTING NUCLEIC ACID SEQUENCES - The present invention provides methods and kits for detecting the presence or absence or amount of a target nucleic acid or at least one variant nucleotide in one or more target nucleic acids contained in a sample using appropriate primers. The invention is based on systems whereby there is extension-dependent degradation of the primers in the presence of the target, which degradation leads to a detectable signal. | 2010-07-22 |
20100184037 | DEATH ASSOCIATED PROTEIN KINASE 1 (DAPK1) AND USES THEREOF FOR THE TREATMENT OF CHRONIC LYMPOCYTIC LEUKEMIA - A method for determining susceptibility to chronic lymphocytic leukemia in a subject includes determining a loss or reduced expression of death associated protein kinase 1 (DAPK1) or fragments or functional equivalents thereof. | 2010-07-22 |
20100184038 | System and Method For the Heterologous Expression of Polyketide Synthase Gene Clusters - A system and method for heterologous expression of polyketide biosynthetic pathways from streptomycetes hosts in | 2010-07-22 |
20100184039 | METHODS AND COMPOSITIONS RELATING TO LABELED RNA MOLECULES THAT REDUCE GENE EXPRESSION - The present invention concerns methods and compositions involving labeled, double-stranded RNA (dsRNA), including siRNA, capable of triggering RNA-mediated interference (RNAi) in a cell. Compositions of the invention include labeled dsRNA for RNAi, which may be a single strand of RNA that basepairs with itself or two separate RNA strands. In some embodiments, the label is fluorescent. The present invention further concerns methods for preparing such composition and kits for implementing such methods. Other methods of the invention include ways of using labeled dsRNA for RNAi. | 2010-07-22 |
20100184040 | COMPOSITIONS AND METHODS FOR DETERMINING LIKELIHOOD OF TWINNING - Collections of polynucleotides useful for estimating breeding value or detecting likelihood of twinning are disclosed. The polynucleotides are used to detect genomic sequences quantitatively associated with the twinning trait. Also disclosed are methods and kits for using the collections to estimate breeding value or predict likelihood of twinning. | 2010-07-22 |
20100184041 | Molecular Indicators of Breast Cancer Prognosis and Prediction of Treatment Response - The present invention relates to quantitative molecular indicators that can guide clinical decisions in breast cancer, such as estrogen receptor (ESR1)-positive, lymph node-negative breast cancer. In particular, the invention concerns certain genes, the varied expression of which indicates the likelihood of recurrence of surgically resected breast cancer in patients who are not treated with a therapeutic agent in the adjuvant setting. In addition, the invention concerns the use of quantitative measurement of the expression of certain genes, including the ESR1 gene, that measure as a continuous variable, to determine (a) the likelihood of a beneficial response to the anti-estrogen therapeutic agent, such as tamoxifen; and (b) the potential magnitude of beneficial response to chemotherapy. | 2010-07-22 |
20100184042 | Processes for quantitative or qualitative detection of single-stranded nucleic acids - This invention provides for compositions for use in real time nucleic acid detection processes. Such real time nucleic acid detection processes are carried out with energy transfer elements attached to nucleic acid primers, nucleotides, nucleic acid probes or nucleic acid binding agents. Real time nucleic acid detection allows for the qualitative or quantitative detection or determination of single-stranded or double-stranded nucleic acids of interest in a sample. Other processes are provided by this invention including processes for removing a portion of a homopolymeric sequence, e.g., poly A sequence or tail, from an analyte or library of analytes. Compositions useful in carrying out such removal processes are also described and provided. | 2010-07-22 |
20100184043 | Detecting Genetic Abnormalities - The present invention is directed to compositions and methods for detecting genetic abnormalities. The present invention encompasses methods and compositions for comparing alleles in a sample containing both maternal and fetal nucleic acids in order to identify genetic abnormalities. | 2010-07-22 |
20100184044 | Detecting Genetic Abnormalities - The present invention is directed to compositions and methods for detecting genetic abnormalities. The present invention encompasses methods and compositions for comparing alleles in a sample containing both maternal and fetal nucleic acids in order to identify genetic abnormalities. | 2010-07-22 |
20100184045 | Methods for sequencing degraded or modified nucleic acids - The invention provides methods and compositions for sequencing DNA or RNA samples that would be impossible to do via standard means. Samples that are part of mixtures or are degraded or modified may be sequenced so that the individual from whom the sample originated can be determined or useful biological information can be associated with the sample. Methods are described that allow high efficiency sequencing of degraded nucleic acid samples such as are typically found with FFPE. Samples from severely degraded sources or that have been treated with preservatives such as formalin may be sequenced. In addition to permitting identification of samples, information about disease or treatment status may also be determined. | 2010-07-22 |
20100184046 | Methods and systems of using exosomes for determining phenotypes - Exosomes can be used for detecting biomarkers for diagnostic, therapy-related or prognostic methods to identify phenotypes, such as a condition or disease, for example, the stage or progression of a disease. Cell-of-origin exosomes can be used in profiling of physiological states or determining phenotypes. Biomarkers or markers from cell-of-origin specific exosomes can be used to determine treatment regimens for diseases, conditions, disease stages, and stages of a condition, and can also be used to determine treatment efficacy. Markers from cell-of-origin specific exosomes can also be used to identify conditions of diseases of unknown origin. | 2010-07-22 |
20100184047 | SCREENING AND THERAPEUTIC METHOD FOR NSCLC TARGETING THE CDCA8-AURKB COMPLEX - The present invention is based on the observation that the co-activation of CDCA8 and AURKB, and their cognate interactions, play a significant role in lung-cancer progression. Accordingly, inhibiting the formation of the CDCA8-AURKB complex finds utility in the treatment of non-small-cell lung cancer. The present invention also provides methods for identifying for compounds suitable for the treatment and/or prevention non-small-cell lung cancer, using, for example, the transcriptional regulatory region of the CDCA8 or AURKB gene, as well as diagnostic and prognostic methods that utilize the expression levels of CDCA8 and/or AURKB as a determining index. | 2010-07-22 |
20100184048 | EPIDERMAL GROWTH FACTOR (EGF) EXPRESSION AND/OR POLYMORPHISMS THEREOF FOR PREDICTING THE RISK OF DEVELOPING CANCER - The present invention relates to diagnostic and prognostic methods to determine the likelihood of a subject who has a inflammatory disease or liver disease of developing cancer. In particular, the present invention relates to methods for identifying subjects with increased susceptibility to developing cancer, such as hepatocellular carcinoma (HCC) where the subject has an inflammatory disease, such as, but not limited to cirrhosis, by identifying a variance or polymorphism in the human EGF gene. In particular, the methods of the present invention relate to identifying subjects with increased susceptibility to developing cancer such as HCC, where the subject has an inflammatory disease, such as but not limited to cirrhosis, and the subject is identified to have a single nucleotide polymorphism 61A>G in the 5′UTR of the EGF gene. Alternatively, the methods of the present invention relate to identifying subjects with increased susceptibility to developing cancer such as HCC, where the subject has an inflammatory disease, such as but not limited to cirrhosis, and the subject is identified to have increased expression of EGF as compared to a reference level of EGF expression. The present invention also relates to administering an effective amount of an anti-cancer therapy to subjects identified to have an increased susceptibility of developing cancer such as HCC by the methods as disclosed herein, and kits to identify a subject with a 61A>G polymorphism in the 5′UTR of the EGF gene or kits to determine increased EGF expression in subjects with chronic inflammatory disease. | 2010-07-22 |
20100184049 | Glycoprotein Profiling of Bladder Cancer - The present invention relates to a method for the diagnosis, prognosis, and monitoring of bladder cancer, such as early or late stage bladder cancer, by detecting in a urine sample from a subject at least one biomarker for bladder cancer identified herein, such as alpha-1B-glycoprotein, haptoglobin, serotransferrin, or alpha- | 2010-07-22 |
20100184050 | DIAGNOSIS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE IN THE PUERTO RICAN POPULATION - This invention provides methods of diagnosis and treatment of inflammatory bowel disease. In one embodiment, the invention provides methods of diagnosing and/or predicting susceptibility for inflammatory bowel disease in the Puerto Rican population by determining the presence or absence of a risk variant at the HPS1 locus. In another embodiment, the invention further provides methods of diagnosing and/or predicting protection against inflammatory bowel disease by determining the presence or absence of a protective variant at the IRF1 locus. In another embodiment, the presence in an individual of a risk variant at the CARD8 locus is diagnostic of susceptibility to Crohn's Disease in a Puerto Rican individual. In another embodiment, the presence of a risk variant at the TLR-9 locus in an individual is diagnostic of susceptibility to Crohn's Disease. | 2010-07-22 |
20100184051 | METHODS OF GENERATING PLURIPOTENT CELLS FROM SOMATIC CELLS - Disclosed herein are methods to select for the generation of mouse and human pluripotent stem cells during developmental reprogramming. The methods described herein relate to the selection of induced pluripotent stem cells, i.e., pluripotent stem cells generated or induced from differentiated cells without a requirement for genetic selection. Described herein are particular embodiments for selection of reprogrammed cells based on 1) colony morphology, or 2) X chromosome reactivation in female cells. | 2010-07-22 |
20100184052 | PROGNOSTIC GENE EXPRESSION SIGNATURE FOR NON SMALL CELL LUNG CANCER PATIENTS - The invention relates to a method of typing non-small cell lung cancer cells by determining RNA levels for a set of genes. Said typing can be used for determining a metastasizing potential of the cancer cells. The invention further relates to a set of probes and a set of primers that can be used for typing non-small cell lung cancer cells. | 2010-07-22 |
20100184053 | IDENTIFICATION AND QUANTIFICATION OF ONCOGENIC HPV NUCLEIC ACIDS BY MEANS OF REAL-TIME PCR ASSAYS - Method for the identification and quantification of oncogenic HPV nucleic acids comprising: a) first line screening by means of 5 independent SYBR Green I Real-time PCR assays to determine the total viral load and to identify the presence of one or more of 13 high risk HPV genotypes in the sample; b) second line assays to be applied to samples positives for: 5 independent TaqMan Real-time PCR assays to determine the presence and the viral load of the most common oncogenic HPV types: HPV types: 16, 18, 31, 45, 33 group (including 33, 52, 58, 67 genotypes).6 independent SYBR Green I RT Real-time PCR assays to determine the presence in the sample of the oncogenic transcripts E6/E7 of HPV types 16, 18, 31, 33, 45, 58. | 2010-07-22 |
20100184054 | BINDING OF PATHOLOGICAL FORMS OF PRION PROTEINS - A process for the selective binding of an aggregating abnormal form of a protein in the presence of the nonaggregating normal form of the protein, including contacting under selective binding conditions a material containing both the abnormal and normal forms with a binding agent which is a polyionic material having a binding avidity for the aggregating form of the protein as present in the sample. | 2010-07-22 |
20100184055 | Method for Distinguishing Follicular Thyroid Adenoma (FTA) From Follicular Thyroid Carcinoma (FTC) - Follicular thyroid adenoma (FTA) is distinguished from follicular thyroid carcinoma (FTC) by comparing amount of an expression product of at least one gene selected from the group consisting of DDIT3, ARG2, ITM1, C1orf24, TARSH, and ACO1 in a test follicular thyroid specimen to a normal control thyroid specimen. The test follicular thyroid specimen is identified as FTA if the amount of expression product of TARSH is equal to or greater in the test follicular thyroid specimen than in the normal control thyroid specimen. The test follicular thyroid specimen is identified as FTC if the amount of expression product of DDIT3, ARG2, ITM1, C1orf24, or ACO1 is greater in the test follicular thyroid specimen than in the normal control thyroid specimen. | 2010-07-22 |
20100184056 | Sample collection and measurement in a single container by back scattering interferometry - This invention provides a device and method for collection and analysis of heterogeneous samples in a single sample container by back scattering interferometry. The sample container is configured to allow collection of a heterogeneous sample, such as blood, from a subject, separation of insoluble materials, such as blood cells by, for example, centrifugation, and mounting on a back scattering interferometer for analysis. In certain embodiments the container is a capillary tube and the interferometer comprises a mounting to hold the capillary tube in position for analysis. The device and method allow point-of-care analysis of samples. | 2010-07-22 |
20100184057 | Methods and probes for identifying a nucleotide sequence - The present invention provides a method for identifying a set of target nucleotide sequences capable of identifying a member of a group of related nucleotide sequences, the method comprising the step of dividing the nucleotide sequence of each member of the group into a plurality of subsequences, wherein at least two of the subsequences overlap. The method is useful in generating probe sets capable of assigning alleles at HLA or KIR loci. | 2010-07-22 |
20100184058 | PERIPHERICAL TISSUE SAMPLE CONTAINING CELLS EXPRESSING THE 5HTR2C AND/OR ADARS AS MARKERS OF THE ALTERATION OF THE MECHANISM OF THE 5HTR2C MRNA EDITING AND ITS APPLICATIONS - The present invention relates to an in vitro method for predicting a pathology related to an alteration of the mechanism of the mRNA editing of ADAR dependent A to I mRNA editing, particularly the serotonin 2C receptor (5HTR2C), in a patient from a peripherical tissue sample containing cells expressing said mRNA, such as the 5HTR2C mRNA, and/or adenosine deaminases acting on RNA (ADARs), such as skin and/or blood tissue sample. The present invention further comprises a method for identifying if an agent is capable of in vivo modifying the editing of the 5HTR2C mRNA in brain tissue or to control the efficiency of a drug intended to prevent or to treat a pathology related to an alteration of the mechanism of the 5HTR2C mRNA editing brain tissue, these methods comprising the implementation of said peripherical tissue markers. In a particular aspect, the present invention relates to such methods wherein the 5HTR2C mRNA editing rate or profile, when it is necessary, is determined by a single strand conformation polymorphism (SSCP) method after amplification by a PCR, preferably by a nested PCR, of the specific mRNA fragment containing the edition sites, making it possible, under given analytical conditions, to obtain the editing rate and/or profile of this edited 5HTR2C mRNA from said peripherical tissue. Finally the invention relates to particular nucleic acid primers implemented in said nested PCR. | 2010-07-22 |
20100184059 | COMPOSITIONS - A composition for carrying out a chemical or biochemical reaction, said composition being in a freeze-dried form and comprising (i) a set of reagents comprising at least some of the chemical or biochemical reagents necessary for conducting said chemical or biochemical reaction, including at least one reagent which is fluorescent (ii) a glass forming agent, and (iii) threonine. Kits comprising these compositions and methods of using them form a further aspect of the invention. | 2010-07-22 |
20100184060 | METHOD FOR THE IDENTIFICATION OF PROPANE-OXIDIZING BACTERIA - The invention relates to a method for the identification of propane-oxidizing bacteria which is based on the identification of at least one fragment of the prmA gene encoding the alpha subunit of the propane monooxygenase enzyme and/or the prmD gene encoding an ancillary protein involved in the oxidation reaction of propane by gene amplification in the presence of pairs of primers selected in correspondence of homologous portions, deduced from the alignment of the prmA and prmD sequences. | 2010-07-22 |
20100184061 | REAGENT AND REAGENT KIT FOR ANALYSIS OF IMMATURE LEUKOCYTE - The present invention provides a reagent for analysis of immature leukocytes comprising:
| 2010-07-22 |
20100184062 | Method for Identifying and Quantifying Organic and Biochemical Substances - The invention relates to a method for identifying organic or biochemical substances and for determining their concentration in a fluid medium using a nanogap sensor that comprises at least two electrodes. The invention is characterized in that: a nanogap sensor) with electrodes of different materials is used, a respective probe molecule is bonded to each surface of the two electrodes of the sensor and the free remainder of the probe molecules have at least one bondable group with specificity for bonding to a sought substance or to an analyte molecule in the fluid medium. The analyte molecule has at least two binding sites and passes selectively out of the fluid medium in which it is contained, binds to the free ends of the probe molecules, forming a bridge with the probe molecule, and modifies the resulting impedance between the electrodes. The concentration of the substance in the fluid medium can be determined as a result of the modification. | 2010-07-22 |